The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
NOX1 Deficiency Protects From Aortic Dissection in Response to Angiotensin II
Open accessAbstract
Oxidative stress leads to vascular damage and participates in the pathomechanisms of aortic dissection and aneurysm formation. Here we study aortic dissection in mice deficient in the superoxide-generating reduced nicotinamide-adenine dinucleotide phosphate oxidase NOX1. Seven days of treatment with the hypertensive agent angiotensin II (3 mg/kg per day) led to aortic dissection in 23% of wild-type C57BL/6J mice but in only 4% of NOX1-deficient mice ( P =0.05). In contrast, treatment of wild-type C57BL/6J mice with the hypertensive agent norepinephrine (12 mg/kg per day), did not lead to aortic dissection or sudden death, suggesting that hypertension is not sufficient to cause aortic dissection. Interestingly, norepinephrine-dependent blood pressure elevations were conserved in NOX1-deficient mice, demonstrating that, different from angiotensin II, it acts through NOX1-independent hypertensive mechanisms. The resistance of NOX1-deficient mice to angiotensin II-induced aortic dissection suggests a role for NOX1-dependent alterations of the vascular wall. We, therefore, studied gene expression and protease/inhibitor equilibrium. cDNA array analysis demonstrated differential effects of angiotensin II on gene expression in wild-type and NOX1-deficient mice. Tissue inhibitor of metalloproteinase 1 was increased both on the mRNA and the protein level in aortas from NOX1-deficient mice. Thus, our results demonstrate that NOX1 is involved in the mechanisms of angiotensin II-dependent aortic dissection. As one underlying mechanism, we have identified NOX1-dependent suppression of tissue inhibitor of metalloproteinase 1 expression, which could lead to tissue damage through an altered protease/inhibitor balance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NOX1 deletion limits the blood pressure increase elicited by angiotensin II, although it is unclear if basal blood pressure levels are reduced (345, 346, 630).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [346]
Citations
Cites
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989
Self-citationNOX enzymes and the biology of reactive oxygen
Lambeth, J. D. (2004) · Nature Reviews Immunology · doi:10.1038/nri1312 · Cited by 3,125
Rajagopalan, S., Kurz, S. D., Münzel, T. F., Tarpey, M. M., Freeman, B. Α., Griendling, K. K., & Harrison, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118623 · Cited by 2,467
Rajagopalan, S., Meng, X. P., Ramasamy, S., Harrison, D. G., & Galis, Z. S. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119076 · Cited by 1,137
Newby, A. C. (2005) · Physiological Reviews · doi:10.1152/physrev.00048.2003 · Cited by 817
Robust estimators for expression analysis
Hubbell, E. A., Liu, W., & Mei, R. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.12.1585 · Cited by 603
Mouse Models of Abdominal Aortic Aneurysms
Daugherty, A., & Cassis, L. A. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000118013.72016.ea · Cited by 489
Nox1 Is Involved in Angiotensin II–Mediated Hypertension: A Study in Nox1-Deficient Mice
Matsuno, K., Yamada, H., Iwata, K., Jin, D., Katsuyama, M., Matsuki, M., Takai, S., Yamanishi, K., Miyazaki, M., Matsubara, H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.573709 · Cited by 470
Dikalova, A., Clempus, R., Lassègue, B., Cheng, G., McCoy, J., Dikalov, S., Martin, A. S., Lyle, A., Weber, D. S., Weiss, D., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.538934 · Cited by 438
Analysis of high density expression microarrays with signed-rank call algorithms
Liu, W.-M., Mei, R., Di, X., Ryder, T. B., Hubbell, E. A., Dee, S., Webster, T. A., Harrington, C. A., Ho, M.-H., Baid, J., et al. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.12.1593 · Cited by 426
Redox Mechanisms in Blood Vessels
Mueller, C. F. H., Laude, K. M., McNally, J. S., & Harrison, D. G. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000149143.04821.eb · Cited by 351
Role of Oxidative Stress in the Pathogenesis of Abdominal Aortic Aneurysms
McCormick, M. L., Gavrila, D., & Weintraub, N. L. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000257552.94483.14 · Cited by 349
Wang, H. D., Xu, S., Johns, D. G., Du, Y., Quinn, M. T., Cayatte, A. J., & Cohen, R. A. (2001) · Circulation Research · doi:10.1161/hh0901.089987 · Cited by 342
Decreased blood pressure in NOX1‐deficient mice
Gavazzi, G., Banfi, B., Deffert, C., Fiette, L., Schappi, M., Herrmann, F., & Krause, K.-H. (2006) · FEBS Letters · doi:10.1016/j.febslet.2005.12.049 · Cited by 321
Self-citationRole of the Renin-Angiotensin System in Vascular Diseases
Ruiz‐Ortega, M., Lorenzo, Ó., Rupérez, M., Esteban, V., Suzuki, Y., Mezzano, S. A., Plaza, J. J. G., & Egido, J. (2001) · Hypertension · doi:10.1161/hy1201.100589 · Cited by 317
Daugherty, A., Manning, M. W., & Cassis, L. A. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704331 · Cited by 290
NADPH oxidase and endothelial cell function
Ray, R., & Shah, A. M. (2005) · Clinical Science · doi:10.1042/cs20050067 · Cited by 280
Oxidative Stress in Human Abdominal Aortic Aneurysms
Miller, F. J., Sharp, W. J., Fang, X., Oberley, L. W., Oberley, T. D., & Weintraub, N. L. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000013778.72404.30 · Cited by 277
Angiotensin receptors: distribution, signalling and function
Dinh, D. T., Frauman, A. G., Johnston, C. I., & Fabiani, M. E. (2001) · Clinical Science · doi:10.1042/cs1000481 · Cited by 268
Pyagay, P., Héroult, M., Wang, Q., Lehnert, W., Belden, J. R., Liaw, L., Friesel, R. E., & Lindner, V. (2004) · Circulation Research · doi:10.1161/01.res.0000154262.07264.12 · Cited by 254
Wang, M., Zhao, D., Spinetti, G., Zhang, J., Jiang, L.-Q., Pintus, G., Monticone, R. E., & Lakatta, E. G. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000225777.58488.f2 · Cited by 252
Novel NAD(P)H oxidases in the cardiovascular system: Table 1
Griendling, K. K. (2004) · Heart · doi:10.1136/hrt.2003.029397 · Cited by 215
Thomas, M., Gavrila, D., McCormick, M. L., Miller, F. J., Daugherty, A., Cassis, L. A., Dellsperger, K. C., & Weintraub, N. L. (2006) · Circulation · doi:10.1161/circulationaha.105.607168 · Cited by 206
Deem, T. L., & Cook‐Mills, J. M. (2004) · Blood · doi:10.1182/blood-2004-02-0665 · Cited by 200
Kadoglou, N. P. E., & Liapis, C. D. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904125003143 · Cited by 196
Silence, J., Collen, D., & LIJNEN, H. R. (2002) · Circulation Research · doi:10.1161/01.res.0000016501.56641.83 · Cited by 185
Deng, G. G., Martin-McNulty, B., Sukovich, D. A., Freay, A. D., Halks‐Miller, M., Thinnes, T. C., Loskutoff, D. J., Carmeliet, P., Dole, W. P., & Wang, Y. (2003) · Circulation Research · doi:10.1161/01.res.0000061571.49375.e1 · Cited by 182
Rey, F. E., & Pagano, P. J. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000043452.30772.18 · Cited by 177
Gavrila, D., Li, W. G., McCormick, M. L., Thomas, M., Daugherty, A., Cassis, L. A., Miller, F. J., Oberley, L. W., Dellsperger, K. C., & Weintraub, N. L. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000172631.50972.0f · Cited by 172
Models of Experimental Hypertension in Mice
Johns, C. A., Gavras, I., Handy, D. E., Salomão, A., & Gavras, H. P. (1996) · Hypertension · doi:10.1161/01.hyp.28.6.1064 · Cited by 170
Ishii, T., & Asuwa, N. (2000) · Human Pathology · doi:10.1053/hupa.2000.7642 · Cited by 146
Chen, J., Kuhlencordt, P., Astern, J., Gyurko, R., & Huang, P. L. (2001) · Circulation · doi:10.1161/hc4501.099729 · Cited by 144
Ejiri, J. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00523-6 · Cited by 144
Novel isoforms of NADPH oxidase in vascular physiology and pathophysiology
BENGTSSON, S. H. M., Gulluyan, L. M., Dusting, G. J., & Drummond, G. R. (2003) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2003.03929.x · Cited by 136
McCarthy, J. J., Parker, A., Salem, R., Moliterno, D. J., Wang, Q., Plow, E. F., Rao, S., Shen, G., Rogers, W. J., Newby, L. K., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.016584 · Cited by 130
Angiotensin II-Mediated Development of Vascular Diseases
Daugherty, A. (2004) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2004.01.002 · Cited by 121
Angiotensin II induces MMP-2 in a p47phox-dependent manner
Luchtefeld, M., Grote, K., Grothusen, C., Bley, S., Bandlow, N., Selle, T., Strüber, M., Haverich, A., Bavendiek, U., Drexler, H., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.152 · Cited by 119
Lemaître, V., Soloway, P. D., & D'Armiento, J. M. (2003) · Circulation · doi:10.1161/01.cir.0000044915.37074.5c · Cited by 118
Ogata, T., Shibamura, H., Tromp, G. C., Sinha, M., Goddard, K. A. B., Sakalihasan, N., Limet, R., MacKean, G. L., Arthur, C., Sueda, T., et al. (2005) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2005.02.020 · Cited by 117
Narouz-Ott, L., Maurer, P., Nitsche, D. P., Smyth, N. R., & Paulsson, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007223200 · Cited by 97
Yajima, N., Masuda, M., Miyazaki, M., Nakajima, N., Chien, S., & Shyy, J. Y.-J. (2002) · Journal of Vascular Surgery · doi:10.1067/mva.2002.124366 · Cited by 89
Circulating biomarkers of extracellular matrix remodeling and risk of atherosclerotic events
Sundström, J., & Vasan, R. S. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000203891.34890.b5 · Cited by 87
Enhanced abdominal aortic aneurysm in TIMP-1-deficient mice1
Eskandari, M. K., Vijungco, J. D., Flores, A., Borensztajn, J., Shively, V. P., & Pearce, W. H. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2004.07.247 · Cited by 87
Angiotensin II-mediated signal transduction pathways
Saito, Y., & Berk, B. C. (2002) · Current Hypertension Reports · doi:10.1007/s11906-002-0042-1 · Cited by 67
Wessel, J., Topol, E. J., Ji, M. H., Meyer, J. M., & McCarthy, J. J. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.12.013 · Cited by 58
Coronary artery disease and the thrombospondin single nucleotide polymorphisms
Stenina‐Adognravi, O., Byzova, T. V., Adams, J. C., McCarthy, J. J., Topol, E. J., & Plow, E. F. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.01.005 · Cited by 45
Angiotensin in atherosclerosis
Kon, V., & Jabs, K. L. (2004) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200405000-00005 · Cited by 42
Miller, F. J. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000047947.37203.82 · Cited by 25
Gaudin, P., Trocmé, C., Berthier, S., Kieffer‐Jaquinod, S., Boutonnât, J., Lamy, C., Surla, A., Garin, J., & Morel, F. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(00)00084-7 · Cited by 22
Thrombospondins and Premature Coronary Artery Disease
Hamsten, A., & Eriksson, P. O. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000051871.32874.6a · Cited by 5
Cited by
Sorted by citations
Reactive Oxygen Species in Inflammation and Tissue Injury
Mittal, M., Siddiqui, M. R., Tran, K., Reddy, S. P., & Malik, A. B. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5149 · Cited by 4,897
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R. G., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,135
Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets
Drummond, G. R., Selemidis, S., Griendling, K. K., & Sobey, C. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3403 · Cited by 899
Biochemistry, Physiology, and Pathophysiology of NADPH Oxidases in the Cardiovascular System
Lassegue, B. P., Martín, A. S., & Griendling, K. K. (2012) · Circulation Research · doi:10.1161/circresaha.111.243972 · Cited by 780
Nox4 Is a Protective Reactive Oxygen Species Generating Vascular NADPH Oxidase
Schröder, K., Zhang, M., Benkhoff, S., Mieth, A., Pliquett, R., Kosowski, J., Kruse, C., Luedike, P., Michaelis, U. R., Weissmann, N., et al. (2012) · Circulation Research · doi:10.1161/circresaha.112.267054 · Cited by 622
Metadata
- Authors
- Gavazzi, G., Deffert, C., Trocme, C., Schäppi, M., Herrmann, F. R., & Krause, K.-H.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- From the Department of Geriatrics (G.G.) and Groupe de Recherche et d’Etude du Processus Inflammatoire Techniques de I’Ingénierie Médicale et de la Complexité-Imag Unité Mixtede Recherche-Centre National de la Recherche Scientifique 5525 (G.G., C.T.), University Hospital of Grenoble, Grenoble, France; and the Departments of Pathology, Immunology, and Clinical Pathology (C.D., M.S., K-H.K.), Pediatrics (C.D.), and Rehabilitation and Geriatrics (F.R.H.), Geneva Medical Faculty, Geneva, Switzerland.
- Venue
- Hypertension
- Published
- 2007-07
- Volume
- 50
- Issue
- 1
- Pages
- 189-196
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2140545013
- Cited by
- 135
- References
- 50
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 9 · 2023: 2 · 2022: 5 · 2021: 5 · 2020: 6 · 2019: 5 · 2018: 9 · 2017: 3 · 2016: 10 · 2015: 8 · 2014: 7 · 2013: 11 · 2012: 8
- FWCI
- 8.93
- Type
- journal article
- Language
- en
- Open access
- Licence
- cc-by
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Aortic Disease and Treatment Approaches
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Surgery › Aortic aneurysm repair treatments
- Keywords
- NOX1, aortic dissection, angiotensin II, oxidative stress, NADPH oxidase, norepinephrine, TIMP-1, protease-inhibitor balance, vascular wall damage, gene expression, sudden death
- MeSH terms
- NADPH Oxidase 1, Aortic Dissection, Angiotensin II, Animals, Aorta, Thoracic, Aortic Aneurysm, Blood Pressure, Disease Susceptibility, Gene Expression Regulation, Hypertension, Male, Mice, Inbred C57BL, Norepinephrine, RNA, Messenger, Vasoconstrictor Agents, Mice, Knockout, NADPH Oxidases, Tissue Inhibitor of Metalloproteinase-1, Matrix Metalloproteinase 2, Matrix Metalloproteinase 9, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review